Share Twitter LinkedIn Facebook Email Martina A. Sersch, MD, Executive Medical Director at Amgen Inc., shares Safety Profile of Once-Weekly Regimen Was comparable opposed to the twice-weekly regimen at Annual Meeting 2018
What Are the Latest Melanoma Treatment Advances? [87 Slides] Justin Moyers, MD Melanoma and Skin 3 Mins Read
AMTAGVI [lifileucel] FDA Approved Game-Changer in Melanoma Treatment? Here’s What You Need to Know. Melanoma and Skin 5 Mins Read